Document:

Exhibit

Exhibit 10.2
SEPARATION AGREEMENT AND GENERAL RELEASE (“AGREEMENT”)
In return for the mutual promises in this Agreement, FalconStor Software, Inc. (the “Company”), 2 Huntington Quadrangle, Melville, NY 11747, its predecessor companies, and its and their respective stockholders, affiliates, subsidiaries, divisions, successors and assigns and the current and former employees, officers, directors and agents thereof (collectively referred to throughout this Agreement as “Employer”), and Gary Quinn, his heirs, executors, administrators, successors, and assigns (collectively referred to throughout this Agreement as “You”), agree as follows:
1.Purpose.  This is a Separation Agreement between Company and You and an exchange of General Releases of claims between You and the Employer.
2.    Time to Return and Legal Review.  You understand and agree that You have until July 5, 2017 to sign and return this Agreement.  You are advised to consult with an attorney, at your own expense, before signing.  By signing, You acknowledge that Company has advised You to consult with an attorney before signing, at your own expense, and that You have had enough time to do so.  You further understand that if You do not sign and return this Agreement by July 5,  2017, Company shall have no obligation to make any payments or provide any benefits to You under this Agreement.
3.    Revocation.  You may revoke (cancel) this Agreement for a period of seven (7) calendar days after the day You sign this Agreement.  Any revocation within this period must be submitted, in writing, to Jason Pitre, Company’s Director of Human Resources, and state, “I hereby revoke my acceptance of our Agreement.”  The revocation must be personally delivered to Jason Pitre or a person he designates, or mailed to Jason Pitre and received within seven (7) calendar days of your signing of this Agreement and General Release.  This Agreement shall not become effective or enforceable until the revocation period has expired without revocation by You.  If the last day of the revocation period is a Saturday, Sunday, or legal holiday in New York, then the revocation period shall not expire until the next following day which is not a Saturday, Sunday, or legal holiday.
4.    Resignation.  Effective July 1, 2017, You voluntarily resign from all positions, whether as an employee, as an officer, or as a director, at the Company and any of its direct and indirect subsidiaries, foreign or United States entities, effective on July 1, 2017.  Both You and the Company agree that in response to inquiries regarding your departure from the Company both You and the Employer will state that You voluntarily resigned to pursue other opportunities. Furthermore, it is acceptable if You are not in the office every day while the transition is taking place.
5.    Duty of Confidentiality.  You expressly agree and confirm that You will comply with all of the terms and provisions of the Confidentiality, Proprietary Information and Invention Agreement between You and the Company (the “Confidentiality Agreement”).  A copy will be provided to You upon request. 

6.    Return of Company Property; Expenses.  You represent and warrant that, You have returned to Company all property belonging to Company, including but not limited to keycard, master and office keys, computer equipment, files, records, computer access codes, cell phones, beepers, personal digital assistants (such as BlackBerry or iPhone), memoranda, letters, files, computer software, business plans, instruction manuals and any other property whether furnished to You by the Company or which You have prepared or helped to prepare in conjunction with Your employment with Company.  You further agree to return to Company any such property You find in Your possession after the date You sign and deliver this Agreement to Company.  You will submit a final expense report by July 31, 2017.  
7.    Nondisparagement and References.  It is understood and agreed that neither the Company nor its officers and directors or You will disparage the other or any other “Released Party” (as defined in Paragraph 11) or encourage or induce others to disparage Company or any other Released Party.  If the Company receives an inquiry regarding You from a prospective employer, the Employer agrees to confirm the positions You held, the date You were employed by the Company, and that You resigned to pursue other opportunities .  Nothing in this Agreement shall be construed to prevent You, the Company or any Released Party from providing truthful and accurate testimony in any civil, criminal or regulatory proceeding.  Subject to your obligations under the Confidentiality Agreement, nothing in this Agreement shall be construed to prevent You from providing factual information to a prospective employer that you resigned to pursue other opportunities.
8.    Consideration.  
		
	a.
	In consideration for (i) Your signing and returning this Agreement, (ii) Your meeting with the Company’s new  Chief Executive Officer at a mutually agreeable time within seven (7) days of the signing of this Agreement to provide the Company , to the best of your recollection, with a summary of matters that you have been primarily responsible for or have been involved with, (iii) the Company agreeing to eliminate your obligations under Section 6(c) of the Employment Agreement, dated July 24, 2015 between You and the Company (the “Employment Agreement”) and (iv) Your performance of the obligations under this Agreement, the Company agrees to pay You all amounts owed to You through July 24, 2017 under Section 5(b)(iv)(A) of the Employment Agreement (minus applicable withholdings and deductions).  All restricted stock granted to you that has not vested, shall not vest and shall terminate on the date you sign and return this Agreement.  All stock options previously granted to You will be governed by the terms of any option agreement between You and the Company and the Company’s Amended and Restated 2006 Incentive Stock Plan or the 2016 Incentive Stock Plan, as applicable.

		
	b.
	In consideration for (i) Your signing and returning this Agreement, (ii) Your meeting with the Company’s new Chief Executive Officer at a mutually agreeable time within seven (7) days of the signing of this Agreement to provide the Company, to the best of your recollection, with a summary of matters that you have been primarily responsible for or have been involved with, including but not limited to customer 

2

agreements, insurance policies, corporate record keeping, and in-progress work product that needs to be finalized, (iii) the Company agreeing to eliminate your obligations under Section 6(c) of the Employment Agreement, and (iv) Your performance of the obligations under this Agreement, the Company shall reimburse You for the employer’s portion of the premium associated with COBRA coverage  until the earlier of (i) January 31, 2019 or (ii) the first date on which You become eligible for coverage under another group health insurance plan, provided You timely elect and are eligible for COBRA coverage.  The Company will make such payments on your behalf, directly to the appropriate authority on or before the due date for Your payment.
9.    Disclosure of this Agreement.  You acknowledge that You understand that the Company is required to file this Agreement with the SEC within four business days after it is fully executed.  That filing shall be in the form of the Form 8-K which shall state that You resigned to pursue other opportunities and you will have the opportunity to review and comment on a draft of this Form 8-K before it is filed with the SEC and the Parties shall reach a mutually agreeable wording of the contents thereof.
10.    Nonadmission.  You and Company each understand and agree that neither the signing of this Agreement nor the payment of any money or benefits constitutes an admission by Company, or any other Released Party of any wrongdoing.  Company and each other Released Party expressly denies any liability or violation of law.
GENERAL RELEASE OF ALL CLAIMS
11.    Release of Company and other Released Parties.  In consideration of (in return for) the benefits from Company as outlined in Paragraph 8 as well as the release of You pursuant to Paragraph 13, You hereby irrevocably and unconditionally release, waive and forever discharge Company, its affiliates, parents, successors, predecessors, subsidiaries, assigns, stockholders, directors, officers, employees, representatives, agents, and attorneys (collectively, the “Released Parties”), from any and all claims, agreements, causes of action, demands, or liabilities of any nature whatsoever, including under the Company’s Amended and Restated 2005 Key Executive Severance Protection Plan, the Company’s 2016 Stock Incentive Plan or  the Company’s Management Incentive Plan for fiscal 2017 or any quarterly period in fiscal 2017 (collectively referred to as “Claims”) arising, occurring or existing at any time prior to the signing of this Agreement or arising out of any facts or circumstances that occurred or existed at any time prior to the signing of this Agreement, whether known or unknown, except as to all claims that cannot be released under applicable law (including Claims of discrimination arising under federal law filed with or through a federal agency) or Claims related to the validity of this Agreement.
Examples of Claims Released.  You understand that this release is intended to and does waive:
		
	a.
	Your ability to file a lawsuit against the Company for any and all Claims arising from or relating to Your employment with Company and/or the termination of Your employment with Company.  This includes, but is not limited to, any and all claims 

3

for breach of Company’s or its predecessor’s policies, rules, regulations, or handbooks or for breach of expressed or implied contracts or expressed or implied covenants of good faith, and any and all claims for promissory estoppel, wrongful discharge, defamation, invasion of privacy, violation of public policy, retaliation, mental distress or any other personal injury; any and all claims for back pay, front pay, or for any kind of compensatory, special or consequential damages, punitive or liquidated damages, attorneys’ fees, costs, disbursements or expenses of any kind whatsoever.
		
	b.
	Any and all claims arising under the Family Medical Leave Act, as amended, that were available on or prior to the date You sign this Agreement, whether known or unknown.

		
	c.
	Any and all claims arising under the Age Discrimination in Employment Act, as amended, that were available on or prior to the date You sign this Agreement, whether known or unknown.

		
	d.
	Any and all other claims of any kind whatsoever that You had or may have against Company or any other Released Party at the time You sign this Release, whether known or unknown.  This includes, but is not limited to, any and all rights or claims of any kind that You may have against Company or any other Released Party arising, existing or occurring (or that arise out of any facts or circumstances that occurred or existed) before You became an employee and/or during any period of time You acted as a consultant to the Company.

		
	e.
	Any and all claims for payment for vacation pay.

This provides examples of the Claims that are waived and is not a complete listing of waived claims.
Notwithstanding the foregoing, nothing in this Agreement shall be construed to prevent You from being indemnified as an officer or Director of the Company pursuant to the Company’s Amended and Restated By-Laws, the Indemnification Agreement, dated June 5, 2017 between You and the Company, or  the General Corporation Law of the State of Delaware or from filing a charge with or participating in an investigation conducted by any governmental agency, including, without limitation, the United States Equal Employment Opportunity Commission (“EEOC”) or applicable state or city fair employment practices agency, to the extent required or permitted by law.  Nevertheless, You understand and agree that You are waiving any relief available (including, for example, monetary damages or reinstatement), under any of the claims and/or causes of action waived in this Paragraph 11, including but not limited to financial benefit or monetary recovery from any lawsuit filed or settlement reached by the EEOC or anyone else with respect to any claims released and waived in this agreement.
12.    No Claims Exist.  You confirm that You have not filed, caused to be filed, or are a party to, any claim, charge, complaint, or action against any Released Party in any court.  In the event that any such claim, charge, complaint, or action is filed in any court and You obtain a 

4

judgment, it is the intent of You and Company parties that all payments made to You under this Agreement shall be offset against (the amount will be deducted from) any judgment You obtain.  You further confirm that You have no known workplace injuries.  In addition, You agree that it is the Company’s policy to comply with all applicable laws and regulations, including its own policies.  You are not aware of any violations of any such applicable laws or Company policies by the Company or anyone associated with the Company.
You agree that you shall not, at any time in the future, encourage any current or former Company employee, or any other person or entity, to file any legal or administrative claim of any type or nature against the Company or any of its directors, officers, or employees. You further agree that you shall not, at any time in the future, assist in any manner any current or former Company employee, or any other person or entity, in the pursuit or prosecution of any legal or administrative claim of any type or nature against the Company or any of its officers or employees, unless pursuant to a duly-issued subpoena or other compulsory legal process. 
13.    Release of You.  In consideration of (in return for) You entering into this Agreement and the release set forth in Section 11, the Company hereby irrevocably and unconditionally releases, waives and forever discharges You from any and all claims, agreements, causes of action, demands, or liabilities of any nature whatsoever (collectively referred to as “Claims”) arising, occurring or existing at any time prior to the signing of this Agreement or arising out of any facts or circumstances that occurred or existed at any time prior to the signing of this Agreement, whether known or unknown or Claims related to the validity of this Agreement other than (i)  any Claims resulting from fraud or gross negligence committed by You, (ii) any Claim that cannot be released under applicable law or (iii) Claims related to the validity of this Agreement.
14.    No Claims Exist.  The Company confirms that it has not filed, caused to be filed, or are a party to, any claim, charge, complaint, or action against You in any court.  
15.    COBRA Rights.  Your regular coverage under Company’s medical and dental plans ends on July 31, 2017.  You become eligible to receive health care continuation coverage under the respective plans under COBRA and under applicable laws the day after the regular coverage under the respective plans ends.  If You timely elect health care continuation coverage under COBRA in accordance with Section 4980B of the Code, You shall be entitled to receive COBRA continuation coverage for eighteen (18) months in accordance with Paragraph 8, and in accordance with the provisions of COBRA, which provisions are more fully explained in the COBRA information provided to You by the Company.  However, You will no longer be eligible for any continuation coverage under COBRA if Your eligibility for continuation coverage ceases pursuant to the provisions of COBRA.
16.    No Entitlement to Severance.  You acknowledge that the compensation You are receiving is being received solely in exchange for Your promises in this Agreement.  You understand that severance pay is not ordinarily available under Company’s policy to employees whose employment relationship ends.  You further acknowledge that You have been paid all wages and provided all benefits (including, but not limited to, base salary, bonuses, and paid time off/vacation).

5

17.    Cooperation.  You shall assist in the orderly transition of all current projects and assignments.  You will sign (and, as necessary, at the Company’s expense, have notarized) all documents as reasonably requested by the Company, including all documents relating to resignation from executive or director positions with the Company’s subsidiaries.
You shall cooperate fully with Company and with Company’s counsel in connection with any present or future, actual or threatened, litigation or administrative proceeding involving Company or any predecessor of Company that relates to events, occurrences or conduct occurring (or claimed to have occurred) during the period of Your employment by Company or any predecessor to Company.  This cooperation by You shall include, at the Company’s expense, but not be limited to (i) being reasonably available for interviews and discussions with Company’s counsel as well as for depositions and trial testimony; (ii) if depositions or trial testimony are to occur, being reasonably available and cooperating in the preparation therefore as and to the extent that Company’s or other party’s counsel reasonably requests; (iii) refraining from impeding in any way Company’s prosecution or defense of such litigation or administrative proceeding; and (iv) cooperating fully in the development and presentation of prosecution or defense of such litigation or administrative proceeding.
You will be reimbursed by Company for reasonable travel, lodging, telephone and similar expenses incurred in connection with such cooperation.
18.    Governing Law.  This Agreement shall be governed by the laws of the State of New York except to the extent preempted by Federal law.
19.    Venue.  Both You and the Company hereby irrevocably waive any objection that they now or hereafter may have to the laying of venue of any action or proceeding arising out of or relating to this Agreement brought in the United States District Court for the Eastern District of New York, or any New York state court in New York City or Nassau or Suffolk counties, and any objection on the ground that any such action or proceeding in either of such Courts has been brought in an inconvenient forum.  This means that if Company sues you for violating this Agreement, Company may do so in a state or federal court located in New York, including Suffolk County.  
20.    Waiver of Jury Trial.  TO THE EXTENT PERMITTED BY APPLICABLE LAW, YOU AND THE COMPANY IRREVOCABLY WAIVE YOUR RESPECTIVE RIGHTS TO A JURY TRIAL WITH RESPECT TO ANY ACTION, CLAIM OR OTHER PROCEEDING ARISING OUT OF ANY DISPUTE IN CONNECTION WITH THIS AGREEMENT, ANY RIGHTS OR OBLIGATIONS HEREUNDER, OR THE PERFORMANCE OF SUCH RIGHTS AND OBLIGATIONS.  This means that only a judge, not a jury, will decide any lawsuit.
21.    Amendment.  This Agreement may not be modified, altered or changed except upon express written consent of both parties in a document that specifically refers to this Agreement.
22.    Severability.  Each provision of this Agreement is severable from the entire Agreement.  In the event that any provision is declared invalid or unenforceable, that provision shall be amended if possible to be enforceable, but in any event, the remaining provisions of this Agreement shall remain in effect.

6

23.    Entire Agreement.  You and the Company agree that: (a) this Agreement contains the entire agreement between the Released Parties,  the Company and You; and (b) that neither Company, any other Released Party, nor You has made any other representations except those set forth in this Agreement to induce the other parties to agree to this Agreement.
YOU ACKNOWLEDGE THAT YOU HAVE READ THIS AGREEMENT, THAT YOU HAVE BEEN GIVEN AN OPPORTUNITY TO HAVE ANY PARAGRAPHS EXPLAINED, AND THAT YOU UNDERSTAND EACH PARAGRAPH OF THE AGREEMENT.
YOU HAVE BEEN ADVISED THAT YOU HAVE TWENTY-ONE (21) CALENDAR DAYS TO CONSIDER THIS AGREEMENT AND YOU HAVE BEEN ADVISED IN WRITING TO CONSULT WITH AN ATTORNEY BEFORE SIGNING THIS AGREEMENT.
YOU AGREE THAT ANY MODIFICATIONS, MATERIAL OR OTHERWISE, MADE TO THIS AGREEMENT DO NOT RESTART OR AFFECT IN ANY MANNER THE ORIGINAL TWENTY-ONE (21) CALENDAR DAY CONSIDERATION PERIOD.
HAVING ELECTED TO SIGN THIS AGREEMENT, TO FULFILL THE PROMISES SET FORTH IN THIS AGREEMENT, AND TO RECEIVE THE AMOUNTS SET FORTH IN PARAGRAPH “8” ABOVE, YOU FREELY AND KNOWINGLY, AND AFTER DUE CONSIDERATION, ENTER INTO THIS AGREEMENT INTENDING TO WAIVE, SETTLE AND RELEASE ALL CLAIMS YOU HAVE OR MIGHT HAVE AS OF THE DATE OF SIGNING AGAINST THE COMPANY OTHER THAN SET FORTH IN PARAGRAPH 11 ABOVE.
IN WITNESS WHEREOF, the parties hereto knowingly and voluntarily executed this Agreement as of the date set forth below:
	
					
	 
	NAME
	 
	 
	FalconStor Software, Inc.

	By:
	/s/ Gary Quinn
	 
	By:
	/s/  Daniel Murale

	 
	Gary Quinn
	 
	 
	Daniel Murale 
Executive Vice President, Chief Financial Officer and Treasurer

	Date:
	June 14, 2017
	 
	Date:
	June 14, 2017

7EX-10.1

 Exhibit 10.1 

[ADVERUM BIOTECHNOLOGIES, INC. LETTERHEAD] 
 June
15, 2017 
 Athena Countouriotis, M.D. 
 *** 

Re: Employment Terms for Senior Vice President & Chief Medical Officer 

Dear Dr. Countouriotis: 
 This letter agreement (the
“Agreement”) memorializes the employment terms for your anticipated hire by Adverum Biotechnologies, Inc. (the “Company”) in the position of Senior Vice President & Chief Medical Officer reporting to Amber Salzman,
President & Chief Executive Officer. These terms will become effective on June 19, 2017, or at a later date determined by mutual agreement and approved by the Board of Directors of the Company (as applicable, the “Hire Date”).

 Effective as of the Hire Date, your employment terms will be as follows: 
  

	1.	Compensation and Benefits. 

 Your base salary will be $460,000 annually, subject to payroll deductions
and all required withholdings, representing full-time employment with the Company. Your salary will be paid in accordance with the Company’s standard payroll schedule. 

In addition, for each calendar year starting 2017 you will be eligible to earn an annual performance bonus with a target bonus amount equal to Forty Percent
(40%) of your salary earned during the bonus year, provided that you are actively employed from the Hire Date through and including the date the bonus is paid. Your annual bonus will be calculated based on attainment of individual goals (including
corporate and personal objectives) to be determined by the Company’s management each year. Any bonus for 2017 may be prorated based on your Hire Date. Bonus payments will be in the form of cash and/or incentive stock options, and will be
granted at the discretion of the Company’s CEO and Board of Directors. Any cash bonus payments will be less payroll deductions and all required withholdings. 

You will be eligible to participate in the Company’s general employee benefits in accordance with the terms, conditions and limitations of any such
benefit plans, as in effect from time to time. 
 For your regular work week, you are agreeing to be on-site at our
Menlo Park, CA headquarters at a minimum of two (2) consecutive days per week and no more than three (3) consecutive days per week, unless you are traveling to another location on a business-related event. You will be granted Six Thousand
dollars ($6000.00) per month net (which will be grossed up for income taxes) as an allowance for expenses associated with the need for you to be on-site at our Menlo Park, CA headquarters. 

  
  

	2.	Incentive Stock Option and Restricted Stock Units grants. 

 In addition to the
compensation and benefits described above, the Company will grant you 213,000 Stock Options, representing the option to purchase shares of the Company’s common stock at a price equal to the closing price of the common stock on the Hire Date.
The foregoing stock option will be granted outside the Company’s 2014 Equity Incentive Plan as an inducement grant and will be subject to the standard form of stock option agreement for an inducement grant (the “Option Agreement”),
and shall provide that 25% of the shares vest after twelve (12) months, and the remaining 75% of the shares vest in equal monthly installments over the following thirty-six (36) months. 

In addition, the Company will grant you 150,000 Restricted Stock Units (“RSUs”). The foregoing RSU award will be granted outside the Company’s
2014 Equity Incentive Plan as an inducement grant and will be subject to the standard form of RSU agreement for an inducement grant, and 25% of the shares of common stock subject to the award of RSUs shall vest and be released on each yearly
anniversary of the Hire Date, such that all shares subject to the award of RSUs shall be vested and released on the fourth (4th) anniversary of the Hire Date. 
  

	3.	Confidentiality and Proprietary Information Obligations. 

  

	 	(a)	Company Policies and Proprietary Information Agreement. You will be required to sign the Employee Proprietary Information and Invention Assignment Agreement attached hereto as Exhibit A (the “Proprietary
Information Agreement”). 

  

	 	(b)	Adverse or Outside Business Activities. Throughout your employment with the Company, you may engage in civic, academic teaching and lectures, and
not-for-profit activities so long as such activities do not interfere with the performance of your duties hereunder or present a conflict of interest with the Company.
You may not engage in other employment or undertake any other commercial business activities unless you obtain the prior written consent of the Company’s CEO. In addition, throughout the term of your employment with the Company, you agree not
to, directly or indirectly, without the prior written consent of the Company, own, manage, operate, join, control, finance or participate in the ownership, management, operation, control or financing of, or be connected as an officer, director,
executive, partner, employee, principal, agent, representative, consultant, licensor, licensee or otherwise with, any business or enterprise engaged in any business which is competitive with or which is reasonably anticipated to be competitive with
the Company’s business; provided, however, that you may purchase or otherwise acquire up to (but not more than) one percent (1%) of any class of securities of any enterprise (but without participating in the activities of such enterprise) if
such securities are listed on any national or regional securities exchange. You hereby represent and warrant that you have disclosed previously to the Board all other employment or other commercial business activities that you already undertake, or
intend to undertake (to the extent currently known by you), during your period of employment with the Company. 

  

	4.	No Conflicts. 

 By signing this Agreement you hereby represent to the Company that, except as previously
disclosed to the Company: (a) your employment with the Company is not prohibited under any employment agreement or other contractual arrangement; and (b) you do not know of any conflicts that would restrict 

  
  

Page 2 

 your employment with the Company. You hereby represent that you have disclosed to the Company any contract you
have signed that may restrict your activities on behalf of the Company, and that you are presently in compliance with such contracts, if any. 
 Subject to
this Section 4, the Company acknowledges that you will be providing consulting services to Halozyme Therapeutics, Inc. on a temporary basis and such consulting services is expected to conclude by the end of August 2017. You acknowledge and
agree that during your employment with Company such consulting services will not interfere in any way with your full-time duties with the Company. The Company may, at its sole discretion, request that you discontinue such consulting services at any
time. 
  

	5.	At Will Employment; Change in Control and Severance Agreement. 

 Subject only to the benefits described
in the Change in Control and Severance Agreement attached hereto as Exhibit B, your employment relationship with the Company will be an “at-will” arrangement. This means that either you or the Company may terminate your employment at any
time, with or without cause, and with or without advance notice. The Company also has the right to reassign you or change your compensation at any time, with or without cause or advance notice. This “at-will” employment relationship cannot
be changed except in a written agreement approved by the Company and signed by you and by a duly authorized officer of the Company. 
  

	6.	Miscellaneous. 

 6.1.    Conditions of employment. As
required by law, your employment is contingent upon satisfactory proof of your identity and legal authorization to work in the United States. Additionally, this offer is contingent upon your completion of the employment application, verification of
your references, satisfactory completion of a pre-employment background check, and execution of the Proprietary Information Agreement and the Acknowledgment of Business Ethics and Conduct Guide and Company
Policies by or on your first day of employment. 
 6.2.    Entire agreement. This Agreement, together with
your Proprietary Information Agreement (Exhibit A) and Change in Control and Severance Agreement (Exhibit B), forms the complete and exclusive statement of your employment agreement with the Company. The employment terms in this Agreement supersede
any other agreements or promises made to you by anyone, whether oral or written, concerning your employment terms. 

6.3.    Succession and assignment. This Agreement is personal to you and shall not be assigned by you. Any
purported assignment by you shall be null and void from the initial date of the purported assignment. The Company may assign this Agreement to any successor or assign (whether direct or indirect, by purchase, merger, consolidation or otherwise) to
all or substantially all of the business or assets of the Company. This Agreement shall inure to the benefit of the Company and permitted successors and assigns. 

6.4.    Enforceability. If any provision of this Agreement is determined to be invalid or unenforceable, in
whole or in part, this determination shall not affect any other provision of this Agreement and the provision in question shall be modified so as to be rendered enforceable in a manner consistent with the intent of the parties insofar as possible
under applicable law. 
 6.5.    Governing law and jurisdiction. This Agreement shall be construed and
enforced in accordance with the laws of the State of California without regard to conflicts of law principles. Any action or proceeding by either of the parties to enforce this Agreement shall be brought only in a state or

  
  

Page 3 

 federal court located in the state of California, county of San Mateo. The parties hereby irrevocably submit to
the exclusive jurisdiction of such courts and waive the defense of inconvenient forum to the maintenance of any such action or proceeding in such venue. 

6.6.    Headings and captions. The captions of the sections of this Agreement are for convenience of
reference only and in no way define, limit or affect the scope or substance of any section of this Agreement. 

6.7.    No construction against drafter. Any ambiguity in this Agreement shall not be construed against
either party as the drafter. 
 6.8.    Waiver. Any waiver of a breach of this Agreement, or rights
hereunder, shall be in writing and shall not be deemed to be a waiver of any successive breach or rights hereunder. 

6.9.    Counterparts. This Agreement may be executed in counterparts, which shall be deemed to be part of
one original, and facsimile signatures shall be equivalent to original signatures. 
 7.    Acknowledgement of Full
Understanding. YOU ACKNOWLEDGE AND AGREE THAT YOU HAVE FULLY READ, UNDERSTAND AND VOLUNTARILY ENTER INTO THIS AGREEMENT. YOU ACKNOWLEDGE AND AGREE THAT YOU HAVE HAD AN OPPORTUNITY TO ASK QUESTIONS AND CONSULT WITH AN ATTORNEY OF YOUR CHOICE
BEFORE SIGNING THIS AGREEMENT. 
 Please sign and date this letter and return it to me by the close of business on June 16, 2017, in order to confirm
your anticipated employment terms as set forth above. 
 We look forward to a productive and enjoyable work relationship with you. 

Sincerely, 
 Adverum Biotechnologies, Inc.: 

 

	
	 /s/ Amber Salzman

	Amber Salzman, President & Chief Executive Officer

 Understood and Accepted: 
  

	
	 /s/ Athena Countouriotis

	Athena Countouritotis

 Date: June 15, 2017 

  
  

Page 4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00272-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00272-of-00352.parquet"}]]